Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00227_DB00238_nanopub.RAnovdD-r3yoFrzcDsi-toBRSeXJ4Fbzxr-QgKoczExaE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00227_DB00238 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00227_DB00238 label "DDI between Lovastatin and Nevirapine - The strong CYP3A4 inducer, nevirapine, may decrase the effect of lovastatin by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of lovastatin if nevirapine is initiated, discontinued or dose changed. [drugbank_resource:DB00227_DB00238]" assertion.
- drugbank_resource:DB00227_DB00238 identifier "drugbank_resource:DB00227_DB00238" assertion.
- drugbank_resource:DB00227_DB00238 title "DDI between Lovastatin and Nevirapine - The strong CYP3A4 inducer, nevirapine, may decrase the effect of lovastatin by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of lovastatin if nevirapine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00227 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00227_DB00238 assertion.
- drugbank:DB00238 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00227_DB00238 assertion.